MQ7-33042-54478
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 740 / OK
- Registered
- 2021-08-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-27
Registered in v-safe
-
2021-08-27
Dose 1 — Pfizer-BioNTech
- 2021-08-27
- 2021-08-28
- 2021-08-29
-
2021-08-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-08-31
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-10
-
2021-09-17
Dose 2 — Pfizer-BioNTech
- 2021-09-17
- 2021-09-18
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-24
- 2021-10-01
- 2021-10-10
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-12-21
-
2022-03-18
Survey response — 6 months, dose 2MedDRA: Discharge, Nasopharyngitis — Feeling: GoodFree text: Drainage with cold-like symptoms.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-27 | Pfizer-BioNTech | No |
| 2 | 2021-09-17 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2
Symptoms: Drainage with cold-like symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Discharge | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release